ORIGINAL RESEARCH article
Front. Microbiol.
Sec. Antimicrobials, Resistance and Chemotherapy
Genomic surveillance of carbapenem-resistant Klebsiella pneumoniae in the Republic of Moldova
Svetlana Colac 1
Livia Tapu 1
Maria Anton 1
Diana Perde 1
Pimlapas Leekitcharoenphon 2
Saria Otani 2
Frank M Aarestrup 2
Olga Burduniuc 1
1. National Agency for Public Health, Chisinau, Moldova
2. Technical University of Denmark, Kongens Lyngby, Denmark
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Abstract
Antimicrobial-resistant Klebsiella pneumoniae poses a global threat to human, animal, and environmental health. The challenges of AMR surveillance have led to the development of advanced molecular biology techniques, such as genomic sequencing, to identify the resistance gene diversity and the factors contributing to the AMR emergence and spreading. In this study, a total of 99 Klebsiella pneumoniae strains suspected of producing ESBL or carbapenemases were collected between January 2020 and December 2023 from nine hospital laboratories, predominantly from hospital-associated infections/isolates. The strains were analysed using conventional methods as well as whole-genome sequencing. Phenotypic testing indicated very high resistance to key antibiotic classes, including third-generation cephalosporins (98%), fluoroquinolones (97%), aminoglycosides (95%), and carbapenems (68%). Subsequent bioinformatic analysis was performed using tools such as iTOL, the Center for Genomic Epidemiology platform, and Kleborate. Sixteen distinct MLST types were identified among the studied strains. The most common were ST395 (N=56), ST377 (N=12), and ST23 (N=5). Phylogenetic inference revealed two major ST395 clusters spanning multiple hospitals, consistent with inter-hospital dissemination. All ST395 strains carried the resistance genes blaOXA-48, blaCTX-M-15, blaOXA-1, blaNDM-1, and blaTEM-1B. Bioinformatic analysis of the sequences showed that most isolates contained 7 of the 8 Col group plasmid/replicon types and 5 of the 21 Inc group types. A high virulence score was observed in 37 strains, while 2 strains showed a very high score. This includes globally transmitted strains such as ST395 and ST23 (hypervirulent), as well as the regionally dominant ST377 lineage, which was highly resistant but not hypervirulent. Our study suggests several independent introductions of K. pneumoniae strains, including carbapenem resistant and hypervirulent strains into Moldova, followed by spread across several hospitals. This includes globally transmitted strains such as ST395 and ST23, as well as regionally dominant strains like ST377. Comprehensive genomic surveillance of AMR has offered crucial insights for tracking multidrug-resistant Klebsiella pneumoniae strains. These findings help shape surveillance priorities and underline the importance of whole-genome sequencing in both research and ongoing monitoring. Such efforts are essential for guiding effective prevention and control strategies to limit the spread of resistant K. pneumoniae in the Republic of Moldova.
Summary
Keywords
Antimicrobial resistance mechanisms, Carbapenem resistance, genomicsurveillance, Klebsiella pneumoniae, Whole-genome sequencing
Received
19 January 2026
Accepted
18 February 2026
Copyright
© 2026 Colac, Tapu, Anton, Perde, Leekitcharoenphon, Otani, Aarestrup and Burduniuc. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Olga Burduniuc
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.